Status:
COMPLETED
Cardiometabolic Devices Accuracy Study
Lead Sponsor:
Foundation for Innovative New Diagnostics, Switzerland
Collaborating Sponsors:
University Hospital, Geneva
B.P. Koirala Institute of Health Sciences
Conditions:
Diabetes Mellitus
Chronic Kidney Diseases
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
With the rise of cardiovascular diseases (CVD) and diabetes, the global disease burden is shifting towards non-communicable diseases (NCDs). An increasing number of low- and middle-income countries (L...
Detailed Description
Independent performance evaluation of POC devices have shown that many devices, regardless of their intended use, do not perform as well as the manufacturers' claims may suggest. There are a variety o...
Eligibility Criteria
Inclusion
- 20 years or older (in line with KHDC eligibility age)
- Attending the Dhulabari PHC facility or Kakarvitta health post in the context of the KHDC program
- Haemoglobin levels ≥8 g/dL
- Able and willing to provide informed consent
Exclusion
- Inability to provide sufficient capillary or venous whole blood sample for all tests
- Haemoglobin levels \< 8g/dL
- Anyone attending the Dhulabari PHC facility or Kakarvitta health post for other reasons than the KHDC program
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
359 Patients enrolled
Trial Details
Trial ID
NCT05257564
Start Date
February 14 2022
End Date
June 30 2022
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
B.P Koirala Institute of Health Sciences
Dharān, Sunsari, Nepal, 56700